Dermatology

Our team's expertise in dermatology trials is rooted in a deep understanding of skin biology, immunology, and the nuances of patient-centered care.

We specialise in the design and execution of clinical trials across a wide range of dermatological conditions, ensuring high-quality data capture and patient safety.

Our clinical team have experience in:
  • Psoriasis: Expertise in evaluating new treatments targeting immune pathways involved in chronic plaque psoriasis.
  • Atopic Dermatitis: Proficiency in assessing novel therapies for this common and complex skin condition, including biologics and small molecules.
  • Acne: Experience in conducting trials for both topical and systemic treatments, with a focus on reducing scarring and improving patient quality of life.
  • Melanoma and Non-Melanoma Skin Cancers: Specialisation in immuno-oncology approaches, targeted therapies, and combination treatments for skin cancer.
  • Rare Dermatological Conditions: In-depth knowledge of conditions such as Epidermolysis Bullosa, Hidradenitis Suppurativa, and other rare skin diseases.

Disciplined,

Cost-Efficient Execution

while maintaining the Highest Quality

Local Trials,

Global Approvals

Access FDA Regulatory Expertise

Our Clinical Team has over

120

years

of Combined Clinical Trial Experience

Addressing Common Pain Points Associated with Dermatology Clinical Trials 

Identifying and engaging patients for dermatology trials, particularly those with rare or stigmatised conditions, can be difficult.

iNGENū CRO addresses this pain point with Enhanced Recruitment Strategies

We utilise targeted recruitment campaigns and partnerships with dermatology clinics and patient advocacy groups to identify and retain patients. Our patient-centric approach, including remote monitoring and teledermatology, enhances participation and reduces dropout rates.

Dermatological assessments often rely on visual inspections, which can be subjective and vary between evaluators.

iNGENū addresses this pain point with Objective Skin Assessments

To reduce subjectivity, we incorporate digital imaging technologies and automated analysis tools in our trials. We also provide thorough training for clinical evaluators to ensure consistent and accurate assessments.

The visible nature of many skin conditions can lead to strong placebo responses, complicating the interpretation of trial results.

iNGENū addresses this pain point with Robust Blinding and Statistical Techniques

iNGENū designs dermatology trials with rigorous blinding procedures and applies advanced statistical methods to mitigate placebo effects, ensuring the integrity of trial outcomes.

Ensuring consistency in the use of scoring systems such as PASI (Psoriasis Area and Severity Index) or EASI (Eczema Area and Severity Index) across multiple sites can be challenging.

iNGENū addresses this pain point with Standardised Scoring Systems

We standardise the use of scoring systems across all sites, with regular calibration exercises and centralised review processes to ensure uniformity in data collection and analysis.

Dermatology trials often involve long-term treatments, necessitating rigorous safety monitoring for adverse effects, especially in chronic conditions.

iNGENū addresses this pain point with Comprehensive Safety Monitoring

Our trials are supported by cutting-edge safety monitoring systems that track patient outcomes in real-time. We prioritise long-term safety, particularly for chronic dermatological conditions, ensuring that patients are protected throughout the study duration.

Dermatology Clinical Trial Resources

iNGENu CRO - Advancing Melanoma Clinical Trials

Melanoma

Overcoming Challenges and Enhancing Protocols in Melanoma Clinical Research.

Read our whitepaper
Atopic Dermatitis - iNGENū CRO

Atopic Dermatitis

Diagnosis, Drug Candidates, and Trial Enhancements in Atopic Dermatitis Clinical Trials.

Read our whitepaper
Acne Vulgaris - iNGENū CRO

Acne Vulgaris

Explore key insights into Epidemiology, Endpoints, and Safety Considerations.

Read our whitepaper
Psoriasis - iNGENū CRO

Psoriasis

Clinical Endpoints, Safety Concerns, and Therapeutic Innovations.

Read our whitepaper
Overcoming Challenges in Cutaneous Lupus Erythematosus Clinical Trials - iNGENū CRO (1)

Cutaneous Lupus Erythematosus

Insights into overcoming challenges in CLE Clinical Trials.

Read our whitepaper

The iNGENū CRO Difference

iNGENu - FDA
Local Trials, Global Approvals

We uniquely combine Australian expertise with direct FDA submission capabilities, offering a streamlined path for sponsors to achieve global approval. Our seamless integration allows trial data from Australia to be submitted directly to the FDA via our E-Gateway, eliminating the need for third-party intermediaries.

iNGENu - cost efficient
Disciplined, Cost-Efficient Execution

iNGENū CRO takes a highly strategic and disciplined approach to clinical research, ensuring that every dollar is directed toward generating meaningful outcomes. Our trials are designed with efficiency in mind, eliminating unnecessary costs while maintaining the highest scientific and regulatory standards.

iNGENu - APAC
Australian-Headquartered, Asia-Pacific Reach

We provide sponsors with comprehensive trial capabilities across the Asia-Pacific region, offering a seamless combination of cost-efficiency and high-quality clinical trials. We leverage the region's competitive pricing while maintaining rigorous Australian-based project management and clinical oversight.

"We have been using iNGENū for a Phase 1, first-in-human trial of our investigational drug. We have used iNGENū for: Medical writing, project management, clinical data management and full end-to-end, clinical trial execution and monitoring.

We have been very happy with all aspects of the management of the clinical trial and have been particularly impressed by the out-of-the-box creative solutions to speed up and reduce overheads for our company during this clinical trial."

Giles Moss
Chief Executive Officer

iNGENu testimonial-logos-monotone-1

Ready to discuss your Dermatology Clinical Trial?

 
Ready to discuss your trial?